These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 27139920)

  • 1. Targeted Nanoparticles for the Delivery of Novel Bioactive Molecules to Pancreatic Cancer Cells.
    Sanna V; Nurra S; Pala N; Marceddu S; Pathania D; Neamati N; Sechi M
    J Med Chem; 2016 Jun; 59(11):5209-20. PubMed ID: 27139920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and Synthesis of Novel Reactive Oxygen Species Inducers for the Treatment of Pancreatic Ductal Adenocarcinoma.
    Kuang Y; Sechi M; Nurra S; Ljungman M; Neamati N
    J Med Chem; 2018 Feb; 61(4):1576-1594. PubMed ID: 29328656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour-specific delivery of siRNA-coupled superparamagnetic iron oxide nanoparticles, targeted against PLK1, stops progression of pancreatic cancer.
    Mahajan UM; Teller S; Sendler M; Palankar R; van den Brandt C; Schwaiger T; Kühn JP; Ribback S; Glöckl G; Evert M; Weitschies W; Hosten N; Dombrowski F; Delcea M; Weiss FU; Lerch MM; Mayerle J
    Gut; 2016 Nov; 65(11):1838-1849. PubMed ID: 27196585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Anti-Tumor Activity of Afatinib in Pancreatic Ductal Adenocarcinoma Cells.
    Ye Z; Li Y; Xie J; Feng Z; Yang X; Wu Y; Zhao K; Pu Y; Xu X; Zhu Z; Li W; Pan J; Chen W; Xing C
    Anticancer Agents Med Chem; 2020; 20(12):1447-1458. PubMed ID: 32384038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric peptide supramolecular nanoparticles for plectin-1 targeted miRNA-9 delivery in pancreatic cancer.
    Wu Y; Tang Y; Xie S; Zheng X; Zhang S; Mao J; Wang B; Hou Y; Hu L; Chai K; Chen W
    Theranostics; 2020; 10(3):1151-1165. PubMed ID: 31938057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancer.
    Pathania D; Sechi M; Palomba M; Sanna V; Berrettini F; Sias A; Taheri L; Neamati N
    Biochim Biophys Acta; 2014 Jan; 1840(1):332-43. PubMed ID: 23954204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ectopic high endothelial venules in pancreatic ductal adenocarcinoma: A unique site for targeted delivery.
    Bahmani B; Uehara M; Ordikhani F; Li X; Jiang L; Banouni N; Ichimura T; Kasinath V; Eskandari SK; Annabi N; Bromberg JS; Shultz LD; Greiner DL; Abdi R
    EBioMedicine; 2018 Dec; 38():79-88. PubMed ID: 30497977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-(6-Phenylimidazo [2,1-
    Cascioferro S; Li Petri G; Parrino B; El Hassouni B; Carbone D; Arizza V; Perricone U; Padova A; Funel N; Peters GJ; Cirrincione G; Giovannetti E; Diana P
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31947550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological Activity and Physicochemical Properties of Dipeptidyl Nitrile Derivatives Against Pancreatic Ductal Adenocarcinoma Cells.
    Quilles JC; Bernardi MDL; Batista PHJ; Silva SCM; Rocha CMR; Montanari CA; Leitão A
    Anticancer Agents Med Chem; 2019; 19(1):112-120. PubMed ID: 30370859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and cytotoxicity testing of novel 2-(3-substituted-6-chloro-1,1-dioxo-1,4,2-benzodithiazin-7-yl)-3-phenyl-4(3H)-quinazolinones.
    Pomarnacka E; Maruszak M; Langowska K; Reszka P; Bednarski PJ
    Arch Pharm (Weinheim); 2008 Aug; 341(8):485-90. PubMed ID: 18618486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-associated fibroblasts in pancreatic adenocarcinoma.
    Pan B; Liao Q; Niu Z; Zhou L; Zhao Y
    Future Oncol; 2015 Sep; 11(18):2603-10. PubMed ID: 26284509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and functionalization of protease-activated nanoparticles with tissue plasminogen activator peptides as targeting moiety and diagnostic tool for pancreatic cancer.
    Dobiasch S; Szanyi S; Kjaev A; Werner J; Strauss A; Weis C; Grenacher L; Kapilov-Buchman K; Israel LL; Lellouche JP; Locatelli E; Franchini MC; Vandooren J; Opdenakker G; Felix K
    J Nanobiotechnology; 2016 Dec; 14(1):81. PubMed ID: 27993133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondria-Targeted Analogues of Metformin Exhibit Enhanced Antiproliferative and Radiosensitizing Effects in Pancreatic Cancer Cells.
    Cheng G; Zielonka J; Ouari O; Lopez M; McAllister D; Boyle K; Barrios CS; Weber JJ; Johnson BD; Hardy M; Dwinell MB; Kalyanaraman B
    Cancer Res; 2016 Jul; 76(13):3904-15. PubMed ID: 27216187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AS1411 aptamer and folic acid functionalized pH-responsive ATRP fabricated pPEGMA-PCL-pPEGMA polymeric nanoparticles for targeted drug delivery in cancer therapy.
    Lale SV; R G A; Aravind A; Kumar DS; Koul V
    Biomacromolecules; 2014 May; 15(5):1737-52. PubMed ID: 24689987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Status and future directions in the management of pancreatic cancer: potential impact of nanotechnology.
    Sielaff CM; Mousa SA
    J Cancer Res Clin Oncol; 2018 Jul; 144(7):1205-1217. PubMed ID: 29721665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antitumor activity of some 2, 3-disubstituted quinazolin-4(3H)-ones and 4, 6- disubstituted- 1, 2, 3, 4-tetrahydroquinazolin-2H-ones.
    Abdel Gawad NM; Georgey HH; Youssef RM; El-Sayed NA
    Eur J Med Chem; 2010 Dec; 45(12):6058-67. PubMed ID: 21051122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and evaluation of benzofuran derivatives as novel anti-pancreatic carcinoma agents via interfering the hypoxia environment by targeting HIF-1α pathway.
    Xu XL; Yang YR; Mo XF; Wei JL; Zhang XJ; You QD
    Eur J Med Chem; 2017 Sep; 137():45-62. PubMed ID: 28554092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syntheses and anti-pancreatic cancer activities of rakicidin A analogues.
    Chen J; Li J; Wu L; Geng Y; Yu J; Chong C; Wang M; Gao Y; Bai C; Ding Y; Chen Y; Zhang Q
    Eur J Med Chem; 2018 May; 151():601-627. PubMed ID: 29656202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of new tricyclic thiolactams as potent antitumor agent for pancreatic cancer.
    Okada T; Minehira D; Takada M; Urata H; Kato A; Adachi I; Kurashima Y; Kaji S; Ogura T; Chiba S; Esumi H; Toyooka N
    Bioorg Med Chem Lett; 2016 Jun; 26(11):2577-9. PubMed ID: 27117432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells.
    Bello C; Bai J; Zambron BK; Elías-Rodríguez P; Gajate C; Robina I; Caffa I; Cea M; Montecucco F; Nencioni A; Nahimana A; Aubry D; Breton C; Duchosal MA; Mollinedo F; Vogel P
    Eur J Med Chem; 2018 Apr; 150():457-478. PubMed ID: 29547833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.